Alcon and LENSAR have decided to terminate a previously agreed-upon merger due to scrutiny from the US Federal Trade Commission (FTC). 1,2. The merger, originally announced in Mar ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

In this video, a visually impaired speaker discusses Mr. Beast's recent effort to pay for cataract surgeries for 1,000 people ...

Enhancement coverage applies within 24 months of the original procedure for refractive and premium lens pathways. Beyond this ...

Cataract surgery is an intervention that can change the way an individual sees the world. As one of the best eye hospitals in Mumbai, Arohi Eye Hospital, has steadily set a new benchmark of cataract ...

HelpMeSee Featured in 'Healthier Together,' Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training ...

NHS waiting times have fallen once more, the Welsh Government has said.

Millions of people in the United States live with impaired vision, suffering daily from cataracts and other treatable eye conditions. Due to not having access to clear, trustworthy information about ...

Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.

One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...

Kochi: Mangala, a then two-month-old tiger cub who was found abandoned near Mangaladevi temple on Tamil Nadu border in Nov ...

Anti-VEGF use for ROP is expanding beyond bevacizumab and ranibizumab, with aflibercept’s fusion-protein structure conferring systemic exposure characteristics distinct from antibody-based agents.